Group 1 - On September 25, Jiahe Meikang's stock rose by 3.20%, with a trading volume of 93.32 million yuan [1] - The financing buy-in amount for Jiahe Meikang on that day was 22.23 million yuan, while the financing repayment was 11.74 million yuan, resulting in a net financing buy-in of 10.50 million yuan [1] - As of September 25, the total balance of margin trading for Jiahe Meikang was 193 million yuan, accounting for 4.73% of its market capitalization [1] Group 2 - As of June 30, the number of shareholders for Jiahe Meikang was 6,655, an increase of 12.93% compared to the previous period [2] - For the first half of 2025, Jiahe Meikang reported operating revenue of 219 million yuan, a year-on-year decrease of 27.22% [2] - The net profit attributable to the parent company for the same period was -116 million yuan, representing a year-on-year decrease of 323.29% [2] Group 3 - The main business of Jiahe Meikang includes medical information software development and industrialization, with revenue composition as follows: software development and technical services 42.39%, self-developed software sales 37.64%, purchased software and hardware sales 19.86%, and other service sales 0.11% [1]
嘉和美康9月25日获融资买入2223.48万元,融资余额1.93亿元